Hikma Ventures

Hikma Ventures is the venture capital arm of Hikma Pharmaceuticals, established in 2015 to broaden the pharmaceutical group's offerings and pursue opportunities in digital health and life sciences. It invests in companies where it believes its expertise and global presence can accelerate revenue growth and help differentiate Hikma's products, working with disruptive technologies and companies it says have a diverse leadership team. Its focus areas include drug delivery, digital therapeutics, clinical trial work, respiratory and central nervous system treatment, and oncology, along with select autoimmune and long-term conditions including type II diabetes and hypertension, and areas addressing overdose and abuse. While stage-agnostic, the firm says it prefers Series A rounds and beyond, is willing to lead or co-lead deals, and takes a long-term view of its portfolio companies.